Department of Microbial Pathogenesis, School of Dentistry, University of Maryland-Baltimore, Baltimore, 21201 MD, USA.
Oradentics Research Institute, Seoul 06157, South Korea.
Pathog Dis. 2017 Mar 1;75(2). doi: 10.1093/femspd/ftx009.
The increasing prevalence of methicillin-resistant Staphylococcus aureus has become a major public health threat. While lactobacilli were recently found useful in combating various pathogens, limited data exist on their therapeutic potential for S. aureus infections. The aim of this study was to determine whether Lactobacillus salivarius was able to produce bactericidal activities against S. aureus and to determine whether the inhibition was due to a generalized reduction in pH or due to secreted Lactobacillus product(s). We found an 8.6-log10 reduction of planktonic and a 6.3-log10 reduction of biofilm S. aureus. In contrast, the previously described anti-staphylococcal effects of L. fermentum only caused a 4.0-log10 reduction in planktonic S. aureus cells, with no effect on biofilm S. aureus cells. Killing of S. aureus was partially pH dependent, but independent of nutrient depletion. Cell-free supernatant that was pH neutralized and heat inactivated or proteinase K treated had significantly reduced killing of L. salivarius than with pH-neutralized supernatant alone. Proteomic analysis of the L. salivarius secretome identified a total of five secreted proteins including a LysM-containing peptidoglycan binding protein and a protein peptidase M23B. These proteins may represent potential novel anti-staphylococcal agents that could be effective against S. aureus biofilms.
耐甲氧西林金黄色葡萄球菌的患病率不断上升,已成为主要的公共卫生威胁。虽然最近发现乳杆菌在对抗各种病原体方面很有用,但关于其治疗金黄色葡萄球菌感染的潜力的数据有限。本研究旨在确定唾液乳杆菌是否能够产生针对金黄色葡萄球菌的杀菌活性,以及抑制作用是否是由于 pH 值普遍降低还是由于分泌的乳杆菌产物引起的。我们发现浮游生物金黄色葡萄球菌减少了 8.6-log10,生物膜金黄色葡萄球菌减少了 6.3-log10。相比之下,先前描述的 L. fermentum 对金黄色葡萄球菌的抗葡萄球菌作用仅导致浮游生物金黄色葡萄球菌细胞减少 4.0-log10,对生物膜金黄色葡萄球菌细胞没有影响。金黄色葡萄球菌的杀伤作用部分依赖于 pH 值,但与营养物质的消耗无关。经 pH 值中和和热失活或蛋白酶 K 处理的无细胞上清液对 L. salivarius 的杀伤作用明显低于单独 pH 值中和的上清液。唾液乳杆菌分泌组的蛋白质组学分析共鉴定出 5 种分泌蛋白,包括一种含有 LysM 的肽聚糖结合蛋白和一种蛋白肽酶 M23B。这些蛋白质可能代表潜在的新型抗葡萄球菌剂,可有效对抗金黄色葡萄球菌生物膜。